Chemed (CHE) Shares Sink as Conspiracy/Defraud Allegations Made Against Co.
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Join SI Premium – FREE
Shares of Chemed (NYSE: CHE) have tumbled sharply Wednesday amid a Bloomberg report which suggests a whistleblower has alleged the company defrauded the US government by conspiring with health insurers to only consider patients who were not dying.
The informant was formerly with Vitas Healthcare, the US's largest provider of hospice care. The whistleblower filed suit in the US District Court in Dallas last week.
Chemed shares last traded at $52.07, down about 9.5 percent from Tuesday's closing price.
The informant was formerly with Vitas Healthcare, the US's largest provider of hospice care. The whistleblower filed suit in the US District Court in Dallas last week.
Chemed shares last traded at $52.07, down about 9.5 percent from Tuesday's closing price.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Nu Skin EVP of global sales takes medical leave
- Gray Media closes $750M note offering to refinance higher-rate debt
Create E-mail Alert Related Categories
Corporate News, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
